Hongbo Lu

Insider Reports History

Entity
Individual
Location
C/O Avedro, Inc., 201 Jones Road, Waltham, MA
Signature
/s/ David Strauss, as Attorney-in-Fact for Hongbo Lu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hongbo Lu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Director Common Stock 476K $5M $10.50 Sep 12, 2024 Indirect
ARROWHEAD PHARMACEUTICALS, INC. Director Common Stock 47.2K $1.08M $22.99 Dec 18, 2024 Direct
Zenas BioPharma, Inc. Director Common Stock 58.8K $1M $17.00 Sep 13, 2024 Indirect
Zenas BioPharma, Inc. Director Stock Option (Right to Buy) 37K Sep 12, 2024 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 10.7K Feb 1, 2025 Direct

Insider Reports Filed by Hongbo Lu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Feb 1, 2025 1 $0 4 Feb 3, 2025 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Dec 18, 2024 1 $385K 4 Dec 20, 2024 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Sep 30, 2024 6 $62.2K 5 Nov 15, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 13, 2024 1 $1M 4 Sep 17, 2024 Director
TERN Terns Pharmaceuticals, Inc. Sep 12, 2024 2 $5M 4 Sep 17, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 1 $0 4 Sep 16, 2024 Director
ZBIO Zenas BioPharma, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jul 1, 2024 1 $0 4 Jul 2, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 14, 2024 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Mar 18, 2024 3 $83K 4 Mar 20, 2024 Director
ARWR ARROWHEAD PHARMACEUTICALS, INC. Mar 15, 2024 0 $0 3 Mar 18, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
TERN Terns Pharmaceuticals, Inc. Dec 23, 2022 1 $5.5M 4 Dec 23, 2022 Director
TERN Terns Pharmaceuticals, Inc. Sep 7, 2022 1 $2.16M 4 Sep 8, 2022 Director
TERN Terns Pharmaceuticals, Inc. Aug 12, 2022 4 $10.6M 4 Aug 16, 2022 Director
TERN Terns Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director